StockData
Pluri Inc. logo

Pluri Inc. (PLUR) stock

PLURNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends June 30
Financials through Q1 FY2027, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 12, 2026Score 4/30
$1.05−0.04 (-3.67%)

Close on Nov 13, 2026Market cap $12.96MP/E –Yield –

Earnings

Pluri's quarterly results as reported in its earnings releases, with the company's own outlook. Hover a number to see the sentence it came from.

Next report
–
Not yet scheduled
Revenue
–
EPS
–
Latest guidance
None
No outlook given in releases

Quarterly results

Revenue and earnings per share from each of Pluri's earnings releases, newest first

QuarterReportedRevenueYoYEPSSource

Figures as first announced; later restatements appear under Financials. Expected dates are estimated from the company's past reporting pattern.

Guidance

Pluri has not given guidance in its releases

Many companies give their outlook only on the conference call or not at all. When Pluri puts a forecast in an earnings release, it is listed here with the exact sentence.

Press releases

Releases Pluri filed with the SEC as exhibits to Form 8-K or 6-K

See a number that looks wrong?